Cell Signaling Technology

CD68 (D4B9C) Rabbit Monoclonal Antibody (InTraSeq™ 3' Conjugate 3012)

#29105 · $434

40
Citing papers
1k
Combined citations
Supplier page Find this product

Research areas

Mycotoxins in Agriculture and Food6Protein Kinase Regulation and GTPase Signaling5Carcinogens and Genotoxicity Assessment5NF-κB Signaling Pathways3interferon and immune responses3Cancer-related Molecular Pathways3Neurofibromatosis and Schwannoma Cases3Cellular transport and secretion2

Papers citing this product

1
Microbial biotransformation of DON: molecular basis for reduced toxicity
Scientific Reports·2016·160 cit.·DOI
2
Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents
Breast Cancer Research·2015·74 cit.·DOI
3
Intestinal toxicity of deoxynivalenol is limited by Lactobacillus rhamnosus RC007 in pig jejunum explants
Archives of Toxicology·2017·72 cit.·DOI
4
In vitro and in vivo effects of a mycotoxin, deoxynivalenol, and a trace metal, cadmium, alone or in a mixture on the intestinal barrier
Environment International·2019·70 cit.·DOI
5
Evidence of the in vitro genotoxicity of methyl-pyrazole pesticides in human cells
Mutation Research/Genetic Toxicology and Environmental Mutagenesis·2012·68 cit.·DOI
6
Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1
Molecular Endocrinology·2008·58 cit.·DOI
7
FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine
BMC Cancer·2016·53 cit.·DOI
8
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
Oncotarget·2015·50 cit.·DOI
9
Group I Paks as therapeutic targets in <i>NF2</i>-deficient meningioma
Oncotarget·2015·48 cit.·DOI
10
Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1
Oncotarget·2016·44 cit.·DOI